Differential gene expression in peripheral blood lymphocytes of cancer patients treated with whole body hyperthermia and chemotherapy: A pilot study

References

• Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes PJ. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia 2003; 19: 267–294
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002; 43: 33–56
   PubMed Web of Science ®Google Scholar
• Jaattelä M. Heat shock proteins as cellular lifeguards. Ann Med 1999; 31: 261–271
   PubMed Web of Science ®Google Scholar
• Kampinga HH, Dynlacht JR, Dikomey E. Mechanism of radiosensitization by hyperthermia (≥43°C) as derived from studies with DNA repair defective mutant cell lines. Int J Hyperthermia 2004; 20: 131–139
   PubMed Web of Science ®Google Scholar
• Lepock JR. Cellular effects of hyperthermia: Relevance to the minimum dose for thermal damage. Int J Hyperthermia 2003; 19: 252–266
   PubMed Web of Science ®Google Scholar
• Urano M, Kuroda M, Nishimura Y. For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia 1999; 15: 79–107
   PubMed Web of Science ®Google Scholar
• Repasky E, Issels R. Physiological consequences of hyperthermia: Heat, heat shock proteins and the immune response. Int J Hyperthermia 2002; 18: 486–489
   PubMed Web of Science ®Google Scholar
• Li CY, Dewhirst MW. Hyperthermia-regulated immunogene therapy. Int J Hyperthermia 2002; 18: 586–596
   PubMed Web of Science ®Google Scholar
• Manjili MH, Wang XY, Park J, Macdonald IJ, Li Y, Van Schie RC, Subjeck JR. Cancer immunotherapy: Stress proteins and hyperthermia. Int J Hyperthermia 2002; 18: 506–520
   PubMed Web of Science ®Google Scholar
• Hammami MM, Bouchama A, Shail E, Aboul Enein HY, al Sedairy S. Lymphocyte subsets and adhesion molecules expression in heatstroke and heat stress. J Appl Physiol 1998; 84: 1615–1621
   PubMed Web of Science ®Google Scholar
• Blazickova S, Rovensky J, Koska J, Vigas M. Effect of hyperthermic water bath on parameters of cellular immunity. Int J Clin Pharmacol Res 2000; 20: 41–46
   PubMedGoogle Scholar
• Downing JF, Taylor MW. The effect of in vivo hyperthermia on selected cytokines in men. Lymphokine Res 1987; 6: 103–109
   PubMedGoogle Scholar
• Kappel M, Stadeager C, Tvede N, Galbo H, Pedersen BK. Effects of in vivo hyperthermia on natural killer cell activity, in vitro proliferative responses and blood mononuclear cell subpopulations. Clin Exp Immunol 1991; 84: 175–180
   PubMed Web of Science ®Google Scholar
• Kraybill WG, Olenki T, Evans SS, Ostberg JR, O’Leary KA, Gibbs JF, Repasky EA. A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: Correlation with mouse models. Int J Hyperthermia 2002; 18: 253–266
   PubMed Web of Science ®Google Scholar
• Ahlers O, Hildebrandt B, Dieing A, Deja M, Bohnke T, Wust P, Riess H, Gerlach H, Kerner T. Stress induced changes in lymphocyte subpopulations and associated cytokines during whole body hyperthermia of 41.8–42.2°C. Eur J Appl Physiol 2005; 95: 298–306
   PubMed Web of Science ®Google Scholar
• Atanackovic D, Nierhaus A, Neumeier M, Hossfeld DK, Hegewisch-Becker S. 41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases. Cancer Immunol Immunother 2002; 51: 603–613
   PubMed Web of Science ®Google Scholar
• Katschinski D, Wiedemann GJ, Longo W, d’Oleire FR, Spriggs D, Robins HI. Whole body hyperthermia cytokine induction: A review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy. Cytokine Growth Factor Rev 1999; 10: 93–97
   PubMed Web of Science ®Google Scholar
• Robins HI, Kutz M, Wiedemann GJ, Katschinski DM, Paul D, Grosen E, Tiggelaar CL, Spriggs D, Gillis W, D’Oleire F. Cytokine induction by 41.8°C whole body hyperthermia. Cancer Lett 1995; 97: 195–201
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Drager J, Kerner T, Deja M, Loffel J, Stroszczynski C, Ahlers O, Felix R, Riess H, Wust P. Whole-body hyperthermia in the scope of von Ardenne's systemic cancer multistep therapy (sCMT) combined with chemotherapy in patients with metastatic colorectal cancer: A phase I/II study. Int J Hyperthermia 2004; 20: 317–333
   PubMed Web of Science ®Google Scholar
• Hegewisch-Becker S, Gruber Y, Corovic A, Pichlmeier U, Atanackovic D, Nierhaus A, Hossfeld DK. Whole-body hyperthermia (41.8°C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: A phase II study. Ann Oncol 2002; 13: 1197–1204
   PubMed Web of Science ®Google Scholar
• Strobl B, Janni W, Rjosk D, Rack BK, Kornya L, Bakhshandeh-Bath A, Hegewisch-Becker S, Hildebrandt B, Sommer HL. Chemotherapy with carboplatin/ifosfamide combined with whole body hyperthermia in recurrent ovarian cancer—results of a phase II study (Dolphin-1-Study). Proc Am Soc Clin Oncol 2002; 19: 2523
   Google Scholar
• Hildebrandt B, Hegewisch-Becker S, Kerner T, Nierhaus A, Bakhshandeh-Bath A, Janni W, Sommer H, Riess H, Wust P. Current status of radiant whole-body hyperthermia at temperatures >41.5. Int J Hyperthermia 2005; 21: 169–183
   PubMed Web of Science ®Google Scholar
• Kerner T, Deja M, Ahlers O, Loeffel J, Hildebrandt B, Wust P, Gerlach H, Riess H. Whole body hyperthermia: A secure procedure for patients with various malignancies?. Intensive Care Med 1999; 25: 959–965
   PubMed Web of Science ®Google Scholar
• Kerner T, Hildebrandt B, Ahlers O, Deja M, Riess H, Draeger J, Wust P, Gerlach H. Anaesthesiological experiences with whole body hyperthermia. Int J Hyperthermia 2003; 19: 1–12
   PubMed Web of Science ®Google Scholar
• Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, et al. Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 1996; 93: 6025–6030
   PubMed Web of Science ®Google Scholar
• Buchner J. Supervising the fold: Functional principles of molecular chaperones. FASEB J 1996; 10: 10–19
   PubMed Web of Science ®Google Scholar
• Garrido C, Gurbuxani S, Ravagnan L, Kroemer G. Heat shock proteins: Endogenous modulators of apoptotic cell death. Biochem Biophys Res Comm 2001; 286: 433–442
   PubMed Web of Science ®Google Scholar
• Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2002; 2: 185–194
   PubMed Web of Science ®Google Scholar
• Menoret A, Chandawarkar R. Heat-shock protein-based anticancer immunotherapy: An idea whose time has come. Semin Oncol 1998; 25: 654–660
   PubMed Web of Science ®Google Scholar
• Tamura Y, Peng P, Liu K, Daou M, Srivastava PK. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 1997; 278: 117–120
   PubMed Web of Science ®Google Scholar
• Narita N, Noda I, Ohtsubo T, Fujieda S, Tokuriki M, Saito T, Saito H. Analysis of heat-shock related gene expression in head-and-neck cancer using cDNA arrays. Int J Radiat Oncol Biol Phys 2002; 53: 190–196
   PubMed Web of Science ®Google Scholar
• Zhang HJ, Drake VJ, Morrison JP, Oberley LW, Kregel KC. Selected contribution: Differential expression of stress-related genes with aging and hyperthermia. J Appl Physiol 2002; 92: 1762–1769, discussion 1749
   PubMedGoogle Scholar
• Kregel KC. Heat shock proteins: Modifying factors in physiological stress response and aquired thermotolerance. J Appl Physiol 2002; 92: 2177–2186
   PubMed Web of Science ®Google Scholar
• Multhoff G. Activation of natural killer cells by heat shock protein 70. Int J Hyperthermia 2002; 18: 576–585
   PubMed Web of Science ®Google Scholar
• Guo XJ, Chambers AF, Parfett CL, Waterhouse P, Murphy LC, Reid RE, Craig AM, Edwards DR, Denhardt DTI. Dentification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: Tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cells. Cell Growth Differ 1990; 1: 333–338
   PubMedGoogle Scholar
• Rossi AM, Hirschhorn RR. Expression of growth-regulated genes in normal and SV40 transformed hamster fibroblasts. J Cell Biochem 1991; 47: 165–173
   PubMedGoogle Scholar
• Chiba T, Nagata Y, Kishi A, Sakamaki K, Miyajima A, Yamamoto M, Engel JD, Todokoro K. Induction of erythroid-specific gene expression in lymphoid cells. Proc Natl Acad Sci USA 1993; 90: 11593–11597
   PubMed Web of Science ®Google Scholar
• Razin SV, Ioudinkova ES, Scherrer K. Extensive methylation of a part of the CpG island located 3.0–4.5 kbp upstream to the chicken alpha-globin gene cluster may contribute to silencing the globin genes in non-erythroid cells. J Mol Biol 2000; 299: 845–852
   PubMedGoogle Scholar
• Dorner BG, Scheffold A, Rolph MS, Huser MB, Kaufmann SH, Radbruch A, Flesch IE, Kroczek RA. MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proc Natl Acad Sci USA 2002; 99: 6181–6186
   PubMedGoogle Scholar
• Minano FJ, Fernandez-Alonso A, Myers RD, Sancibrian M. Hypothalamic interaction between macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta in rats: A new level for fever control?. J Physiol 1996; 491: 209–217
   PubMedGoogle Scholar